Scancell Holdings plc (LON:SCLP – Get Free Report)’s share price crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 13.76 ($0.17) and traded as low as GBX 10 ($0.12). Scancell shares last traded at GBX 10 ($0.12), with a volume of 906,872 shares changing hands.
Scancell Price Performance
The firm has a market capitalization of £92.96 million, a PE ratio of -1,000.00 and a beta of 0.35. The company has a fifty day moving average price of GBX 12.63 and a two-hundred day moving average price of GBX 13.74. The company has a current ratio of 3.42, a quick ratio of 13.01 and a debt-to-equity ratio of 61.41.
Scancell Company Profile
Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel immunotherapies and vaccines for the treatment of cancer and infectious disease. Its product candidates include SCIB1, an ImmunoBody cancer vaccine that is in Phase II for the treatment of metastatic melanoma; and SCIB2/iSCIB2 vaccine, which is under evaluation for the treatment of patients with solid tumors, including non-small cell lung cancer.
Featured Articles
- Five stocks we like better than Scancell
- The 3 Best Blue-Chip Stocks to Buy Now
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- Golden Cross Stocks: Pattern, Examples and Charts
- Nebius Group: The Rising Star in AI Infrastructure
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- MarketBeat Week in Review – 12/30 – 1/03
Receive News & Ratings for Scancell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scancell and related companies with MarketBeat.com's FREE daily email newsletter.
